India's pharmaceutical sector is experiencing rapid growth, with a 7.8% year-on-year increase in April 2025, driven by strong ...

India's pharmaceutical industry, which has emerged as the largest supplier of affordable generic medicines, is poised to grow ...

India’s pharmaceutical sector grew 7.8% in April 2025, driven by exports, innovation, and government schemes, reinforcing its ...

Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.

Trump said he would introduce a “most favoured nation” (MFN) policy whereby the US pays “the same price as the nation that ...

Indian market for these drugs has grown to nearly Rs 600 crore and is expected to keep growing. Weight-loss drugs are ...

By linking US drug prices to those paid in similar economies, order could alter how pharmaceutical companies price their ...

The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...

Torrent Pharmaceuticals reports strong revenue growth in key markets, posting a 15.4% rise in net profit for FY 2024-25.

The proposed 10% tariff, which mirrors India’s tax on US drug imports, could severely impact profit margins for generic drug ...

Indian drugmaker Torrent Pharmaceuticals missed fourth-quarter profit and revenue estimates on Tuesday, hurt by currency depreciation in Brazil, its top overseas market by revenue.

Qure.AI, an India-based startup providing artificial intelligence tools to healthcare firms, is aiming to turn profitable in ...